CDC Hepatitis B Shot Delay: Infection Risk Rises – Studies

A delay in the recommended timing of the first dose of the hepatitis B vaccine for infants could lead to a rise in infections, according to studies highlighted by the University of Nebraska Medical Center. The Centers for Disease Control and Prevention (CDC) is considering a change to its vaccination schedule, prompting concern among medical professionals who recall a time before the vaccine was widely available, when the virus caused severe illness and death, particularly in young children.

The potential shift involves postponing the initial hepatitis B vaccine dose, typically administered within 24 hours of birth, until a later date. This decision stems from a review initiated by the CDC’s Advisory Committee on Immunization Practices (ACIP), a panel appointed by Health and Human Services Secretary Robert F. Kennedy Jr., and is scheduled for discussion during a meeting starting December 4, 2025.

Past Impact of Hepatitis B

Brian McMahon, a liver specialist working at a tribal-owned hospital in Anchorage, Alaska, has witnessed the devastating effects of hepatitis B firsthand. Prior to the introduction of the vaccine in the 1980s, the virus rapidly caused severe liver disease and death in communities across western Alaska.

“One of my patients was 17 years old when I first examined her for stomach pain. McMahon discovered she had developed liver cancer caused by hepatitis B, just weeks before she was set to graduate from high school as valedictorian. She died before the ceremony.”

Brian McMahon, liver specialist

McMahon also recalls the case of an 8-year-old boy who suffered from a rapidly growing liver tumor.

“He was moaning in pain, saying, ‘I know I am going to die soon,'” he recalled. “We were all crying.” The boy died at home a week later.

Brian McMahon, liver specialist

These experiences underscore the importance of preventative measures, such as the birth dose of the hepatitis B vaccine, which has been recommended since 1991. The vaccine is reportedly up to 90% effective in preventing infection when administered within the first 24 hours of life, particularly preventing transmission from mother to child.

How Hepatitis B Spreads

The hepatitis B virus is highly contagious and can be transmitted through even microscopic amounts of blood and bodily fluids. The virus can survive on surfaces for up to a week, increasing the risk of transmission. Both of McMahon’s young patients contracted the virus in early childhood, highlighting the vulnerability of this age group.

The CDC’s consideration of delaying the vaccine is raising concerns that a resurgence of hepatitis B infections could occur, particularly among infants. The potential consequences include an increased risk of chronic liver disease, liver cancer, and even death.

Concerns Over Delayed Vaccination

The decision to review the hepatitis B vaccination schedule is linked to the appointment of a new vaccine advisory panel by Secretary Kennedy Jr. This panel is tasked with re-evaluating existing vaccination recommendations, leading to speculation about potential changes to the standard immunization schedule.

While the CDC has not yet announced a final decision, the possibility of delaying the birth dose of the hepatitis B vaccine has prompted a strong response from medical professionals who emphasize the vaccine’s proven safety and effectiveness. They argue that maintaining the current vaccination schedule is crucial for protecting infants from this potentially life-threatening virus.

The University of Nebraska Medical Center’s reporting on this issue highlights the potential risks associated with altering a long-standing public health strategy that has demonstrably reduced the incidence of hepatitis B and its associated complications.